How We Think - Alzheimer's Disease

These are the posts from the How we think section that have been tagged with Alzheimer's Disease.

To see all tags used in our posts, click here.

Blue Latitude Health - stock image - water cell circle

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Liz Inskip | 18th January 2017

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators in this therapy area are.

read more

Alzheimer's Disease eeviewing the immediate treatment horizon

Alzheimer’s disease: reviewing the immediate treatment horizon

Stuart Goodman | 2nd September 2016

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

read more

photographs-Alzheimers-the-numbers-we-cannot-forget

Alzheimer's: the numbers we cannot forget

David Cooney | 19th July 2016

In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.

read more